DBV Technologies S.A. SEC filings DBVTF
DBV Technologies S.A. has 576 filings in SEC EDGAR's recent list, going back to Jul 25, 2014. Its latest annual report, Form ARS, was filed on May 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Jul 16, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Apr 30, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Oct 28, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Jul 29, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Apr 30, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Jul 30, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Oct 31, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Jul 31, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 1, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 2, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Oct 26, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 2, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 5, 2021 | Mar 31, 2021 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DBVT (Nasdaq), DBVTF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Chatillon
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1613780
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.